Zortress Indication Expanded for Liver Transplant Patients Monthly Prescribing Reference Zortress is currently indicated for organ rejection prophylaxis in renal transplant patients with low-moderate immunologic risk, in combination with basiliximab induction and reduced doses of cyclosporine and corticosteroids. For more information call ... |
